Loading clinical trials...
Loading clinical trials...
Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Children With Type 1 Diabetes Aged 2.0-5.9 Years: Preschool Cohort
Conditions
Interventions
Omnipod Horizon™ Automated Glucose Control System
Locations
10
United States
Stanford University
Palo Alto, California, United States
University of Colorado Denver
Denver, Colorado, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Atlanta Diabetes
Atlanta, Georgia, United States
Joslin Diabetes Center
Boston, Massachusetts, United States
International Diabetes Center
Saint Louis Park, Minnesota, United States
Start Date
September 8, 2020
Primary Completion Date
January 17, 2022
Completion Date
October 12, 2022
Last Updated
February 14, 2024
NCT07224321
NCT07051005
NCT06575426
NCT06390371
NCT06786130
NCT03228732
Lead Sponsor
Insulet Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions